The Robert W. Franz Cancer Research Center is a world-class research facility located inside a cancer care center. Researchers here take novel discoveries from their laboratories and collaborate with physician researchers to “translate” those discoveries into new treatments that can directly benefit people being treated for cancer in the center. This synergistic collaboration between scientists and physicians increases the number of treatment options available to today’s patients, and helps continually generate new ideas that pave the way for tomorrow’s discoveries.
At Providence Cancer Center, patients have access to dozens of clinical trials of promising new drugs and cancer therapies. Many of these new therapies are developed by researchers in the Franz Cancer Research Center, while others come from scientists at other major cancer research institutions. Patients here also have access to a broad range of clinical trials sponsored by pharmaceutical companies. All clinical trials are staffed by teams of physicians, nurses and other cancer specialists who have up-to-the-minute knowledge of the latest treatment options for a variety of cancers. When new treatments prove more effective than standard therapies, patients who participate in clinical trials are among the first to benefit.
By working in close proximity to patients and to each other, Providence researchers, physicians and clinical trials staff members enjoy a collaborative, patient-centered relationship that enhances both research and patient care.